Billing CLIA-Waived Tests

It is not a billing rule, and reading it as one produces the wrong instincts. The requirement sits in 42 U.S.C. 263a(b) (opens in a new tab) and it prohibits something earlier than a claim: no person may solicit or accept materials derived from the human body for laboratory examination unless a certificate is in effect for the laboratory that is applicable to the category of examinations which includes that examination. The prohibited act is taking the specimen. Payment consequences follow, but they are downstream of a rule about conduct.

Two words in that sentence do most of the work. Laboratory is defined in the same section as a facility for examination of materials derived from the human body for the purpose of providing information for diagnosis, prevention or treatment of disease, or for assessing health — which is a description of a physician office with a urine dipstick. CMS's own manual states that CLIA reaches virtually all laboratories including physician office laboratories, and records that while its 1992 instruction to contractors to deny non-compliant laboratory claims excluded those offices, they were brought inside it in 1997. Applicable to the category means the certificate is scoped: holding a certificate and holding the right certificate are different facts, and only the second one is a defence.

The regulation states the same rule from the enforcement side. Under 42 CFR 493.3(a) (opens in a new tab), a laboratory is cited as out of compliance unless it holds a current, unrevoked and unsuspended certificate — of waiver, of registration, of compliance, for provider-performed microscopy procedures, or of accreditation — applicable to the category of examinations it performs, or is CLIA-exempt. Five certificates, one scoping test.

The three exceptions, and how narrow they are

Section 493.3(b) removes only facilities or components that perform testing solely for forensic purposes; research laboratories that test human specimens but do not report patient-specific results for diagnosis, prevention or treatment, or for assessing an individual patient's health; and laboratories certified by the Substance Abuse and Mental Health Services Administration, for the drug testing that meets that agency's guidelines. The last one carries its own limit in the regulation's next sentence: all other testing conducted by such a laboratory is still subject to the rule.

Why this is a revenue-cycle problem and not only a compliance one

Because the consequence is stated in payment terms. Section 493.37(d) provides that failure to meet the certificate-of-waiver requirements results in suspension or denial of payments under Medicare and Medicaid, and § 493.37(e)(3) provides that for laboratories receiving those payments, the suspension takes effect on the date named in the non-compliance notice even where no appeal decision has issued yet. The certificate is upstream of the entire receivable for that testing.

A waived test is one that meets criteria stated at 42 CFR 493.15(b) (opens in a new tab): test systems that are simple laboratory examinations and procedures which are cleared by the Food and Drug Administration for home use, or employ methodologies so simple and accurate as to render the likelihood of erroneous results negligible, or pose no reasonable risk of harm to the patient if performed incorrectly. The statute's version at 42 U.S.C. 263a(d)(3) is worded slightly differently and reaches the same place.

Waived is a fact about a product

This is the sentence to carry away. FDA maintains the current list, and its own database is organised by analyte linked to waived test systems — it records three routes to waived status: a test listed in the regulation; a test system whose manufacturer applies for waiver and supplies scientifically valid data verifying the criteria are met; and a test system cleared by FDA for home use. Two of those three routes are about a specific product.

The consequence for billing is direct. The same analyte can appear in the database under more than one device category — a monitoring device cleared for home use and one restricted to prescription use are separate entries — so two instruments measuring the same substance can differ in waived status, while sharing a procedure code. That is the entire reason a modifier exists here. The code cannot carry the distinction, so something else has to.

There are two separate identifications on the claim and they answer different questions. One says which laboratory performed the test. The other says which test it was, at a level of precision the base code does not reach.

The lists that decide it, and how often they move

None of this is answerable from a static reference, which is the practical reason so much published guidance on it is wrong. CMS distributes three separate lists to its contractors on two different cycles.

• The waived tests, updated quarterly through a recurring update notification. FDA approves waived tests on a rolling basis and CMS passes the result along, so the set a practice bills against changes four times a year.
• The codes that are subject to CLIA edits, updated annually. The manual is explicit that which codes count as a laboratory test under CLIA changes each year, and that a facility submitting a claim for anything on this list must hold a certificate of registration, of compliance, or of accreditation — a certificate of waiver is not among them.
• The codes in the 80000 series that are excluded from CLIA edits, also annual. No CLIA certificate is required for a claim for a test on that list, which is a genuine exception rather than an oversight and is worth knowing before assuming every laboratory-looking code needs a certificate.

The distinction between a rejection and a denial matters more here than in most places, because the two most common CLIA failures produce the first and practices tend to work them as the second.

1. 01

   The CLIA number is missing

   The claim is returned as unprocessable. CMS specifies a particular remittance code combination for this case, so the reason is identifiable on the remittance rather than something to be guessed at — the denial code decoder covers reading those combinations. An unprocessable claim is not an appealable determination, so the remedy is a corrected submission, and the filing clock has not stopped while the claim was out.
2. 02

   The number is present but not in the CLIA format

   Also unprocessable. The format is fixed and short: the first two positions carry a state code based on the laboratory's physical location at registration, the third carries the letter D, and the last seven carry the number unique to that laboratory. A number that fails that shape is rejected without any assessment of the test.
3. 03

   More than one CLIA number is on one claim

   Unprocessable again, with one exception the manual names: where a reference laboratory appears on the same claim. Outside that case, one claim carries one laboratory.
4. 04

   Tests were performed at more than one of the physician's own laboratory locations

   This one surprises people, because nothing about it feels like an error. Where tests on one claim were performed in more than one physician office laboratory by the same physician, the manual requires a separate claim for each location, because each location has its own CLIA number and a claim carries one. A practice with two sites and one billing habit will produce rejections it cannot explain from the coding.
5. 05

   The certificate does not cover the test

   Now it is a denial rather than a rejection, because the claim was processable and the answer was no. CMS specifies a distinct remittance combination for a physician office laboratory out of compliance. This is the failure that a lapsed certificate produces, and it arrives looking like a coding problem.

A certificate is not a permanent fact about a practice, and the intervals that govern it are stated in the statute and the regulation rather than set by a contractor. They are the same for every laboratory.

Two years, at most

A certificate issued under the statute is valid for two years or such shorter period as the Secretary may establish (42 U.S.C. 263a(c)(2)), and § 493.37(e)(1) repeats it for the certificate of waiver specifically. So there is always a next expiry, and it is never more than two years out.

The renewal window opens before it is comfortable

Section 493.37(f)(1) requires a laboratory seeking renewal to complete the prescribed renewal application and return it not less than nine months, and not more than one year, before the certificate expires. A practice that treats renewal as a task for the final quarter has already missed the window the regulation describes.

Thirty days for the changes nobody reports

Section 493.39(b) requires notification within thirty days of a change in ownership, name, location, or director. Every one of those is a thing a practice does for reasons that have nothing to do with laboratory testing, and three of the four change what the claim should say.

Before, not after, for a new kind of test

Section 493.39(a) requires a waived-only laboratory to notify HHS before performing and reporting results for a test not specified under § 493.15 for which it lacks the appropriate certificate, and § 493.37(g) requires it to meet the requirements of the non-waived subparts to do so. Adding a moderately complex test is a certificate change first and a coding question second.

One application per location, with three exceptions

Section 493.35(a) requires a separate application for each laboratory location, and paragraph (b) sets out three narrow exceptions: laboratories not at a fixed location, such as mobile units or health screening fairs, may be covered under a designated primary site; not-for-profit and government laboratories doing limited public health testing — no more than a combination of fifteen moderately complex or waived tests per certificate — may file a single application; and hospital laboratories in contiguous buildings on one campus under common direction may file singly or separately.

1. 01

   Keep a device register, not a code list

   Because waived status attaches to the test system, the record that answers the billing question is an inventory of the instruments and kits actually in use, by location, each mapped to the code it is billed under and to whether that code needs the modifier. A list of codes cannot answer it, and neither can a vendor's assurance from the year the device was bought.
2. 02

   Reconcile the register against the certificate's categories, per location

   The edit compares the test to the certificate held by the laboratory whose number is on the claim. So the check that prevents denials is per site: every test performed at this location, against the categories this location's certificate covers. A practice that consolidated billing across two sites should confirm which number goes on which claim before assuming the coding is the problem.
3. 03

   Re-check the waived list quarterly, not annually

   CMS updates the waived-test list four times a year and the subject-to-edits code list once. Those are different cadences, and a practice reviewing everything annually is working from a list that can be nine months stale on the half that moves fastest.
4. 04

   Do not treat the modifier as a default

   Appending it to every laboratory line is as wrong as omitting it, because some waived tests carry their own code and are identified without it. The question is per code and per device, answered from the current list rather than from a rule of thumb.
5. 05

   Diary the certificate, and diary it early

   Two years is the maximum term and the renewal window opens a full year out. A certificate expiry belongs in the same calendar as enrolment revalidation, because the failure mode is identical: testing continues, claims stop, and nothing in the clinical workflow signals why.
6. 06

   Treat an unprocessable return as a different problem from a denial

   The two most common CLIA failures return the claim rather than denying it. That means no appeal right, no determination to argue with, and a filing period that has been running throughout. Sorting CLIA rejections out of the denial queue is usually the fastest single improvement available here.